JW Pharmaceutical
JW Pharmaceutical is a Seoul drug maker founded in 1945, known for intravenous fluids and nutrition, which sponsors phase 3 cancer trials among its hospital products.
Overview
JW Pharmaceutical, headquartered in Seoul and founded in 1945 as Chungwae, is a Korean pharmaceutical company strong in intravenous solutions, parenteral nutrition and hospital medicines, with a research arm developing targeted drugs. ClinicalTrials.gov lists JW as lead sponsor of a phase 3 trial in a cancer setting.
Similar pages
not linked directly; found by shared links- CompanyCSL Limited
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyD3 Bio (Wuxi)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyDong-A ST
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEndo (now Keenova Therapeutics and Par Health)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEurofarma
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyGrifols
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyInsys Therapeutics
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyIntra-IMMUSG
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.